Drug Use and Addiction Research Programs – Training, Individual

CFDA 93.DA3 Active Grant

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$7.7M FY2026
$8.4M
FY24
$7.6M
FY25
$7.7M
FY26*
* estimated

Program Objective

To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS. To support research training and research scientist development. To support dissemination of research findings.

Eligibility

Eligible Applicants

  • U.S. Federal Government
  • Tribal Government (other)
  • Nonprofit Organization
  • Not-for-Profit Organization
  • Other
  • Small Business Person
  • For-Profit Organization
  • U.S. State Government
  • County Government
  • Municipality/Township Government
  • Other Special District Government
  • Federally Recognized Tribal Government
  • U.S. Territory Government
  • School District
  • Public Housing Authority
  • Tribally Designated Housing Authority

Eligible organizations determined at the NOFO level

How to Apply

Award Procedure

Grants with which the National Advisory Council on Drug Abuse has concurred with the recommendations of the Scientific Review Groups and approved by NIDA for payment are awarded directly by NIDA to the applicant institution.

Decision Timeline

  • Approval: > 180 Days

From 240 to 270 days from submission of grant application. For AIDS applications the range will not exceed 180 days from cited receipt date

Program details & compliance

Description

To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS.

Mission Categories

Primary: Alcoholism and Drug Abuse

Other categories:
Prevention and Control (includes Suicide Prevention)BiologyResearch and DevelopmentSocial Sciences

Required Documentation

See the NIH Grants Policy Statement for further guidance on the applicability of cost principals (http://grants.nih.gov/grants/policy/nihgps/index.htm).
2 CFR 200, Subpart E - Cost Principles applies to this program.

Reporting & Compliance

Audit Required
Yes — Annual
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

Jeanette Marketon — Committee Management Officer, NIDA
3014435239
National Institute on Drug Abuse 3WFN MSC 6024 16071 Industrial Dr. - Dock 11, Gaithersburg, MD 20892
Molly Cluster
3014350503
3WFN MSC 6024 16071 Industrial Dr. - Dock 11,, Gaithersburg, MD 20892
Data from SAM.gov Federal Assistance Listings. Source published: 2026-01-28. Spec v2.0. Last synced: 2026-05-29 05:39:57.